Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) — Form 8-K: Current report
AI-generated summary
Alnylam Pharmaceuticals, Inc. filed a current report on October 29, 2026. The company announced its financial results for the quarter ended September 30, 2026. The full text of the press release was furnished as an exhibit.
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More ALNY filings
- SC 13G
Filed Oct 30, 2026
- 10-Q
Filed Oct 29, 2026
- 4
Filed Oct 6, 2026
- 144
Filed Oct 2, 2026
- 4
Filed Sep 22, 2026
- 10-Q
Filed Jul 30, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.